Skip to main content

Day: September 7, 2023

Mereo BioPharma Reports Interim Financial Results for the Six Months Ended June 30, 2023 and Provides Corporate Update

LONDON, Sept. 07, 2023 (GLOBE NEWSWIRE) — Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on rare diseases, today announced its unaudited interim financial results for the six months ended June 30, 2023 and provided an update on recent corporate highlights. “The first half of 2023 was highlighted by significant updates on each of our lead rare disease programs, as we announced, alongside our partner Ultragenyx, positive data from the dose-selection Phase 2 portion of the Phase 2/3 Orbit study of setrusumab in osteogenesis imperfecta (OI), and we received regulatory guidance around the pivotal study design for alvelestat in Alpha-1 Antitrypsin Deficiency-Associated Lung Disease (AATD-LD),” said Dr. Denise Scots-Knight, Chief Executive Officer of Mereo. “With...

Continue reading

ProQR Announces Webcast of Presentation at the Upcoming HC Wainwright 25th Annual Global Investment Conference

LEIDEN, Netherlands & CAMBRIDGE, Mass., Sept. 07, 2023 (GLOBE NEWSWIRE) — ProQR Therapeutics NV. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer® RNA editing technology platform, today announced that Company management will participate in the HC Wainwright 25th Annual Global Investment Conference. A webcast of the Company’s presentation will be available from the “Investors & Media” section of ProQR’s website under “Events” beginning on September 11, 2023 at 7am EDT. The archived webcast will be available for approximately 30 days. About Axiomer® ProQR is pioneering a next-generation RNA base editing technology called Axiomer®, which could potentially yield a new class of medicines for diverse types of diseases. Axiomer® “Editing Oligonucleotides”,...

Continue reading

Baker Hughes Announces Date for Third Quarter 2023 Earnings Release and Webcast

HOUSTON and LONDON, Sept. 07, 2023 (GLOBE NEWSWIRE) — Baker Hughes (NASDAQ: BKR) will announce the results of the third quarter ending Sept. 30, 2023, via a press release at 5 p.m. Eastern Time (4 p.m. Central Time) on Wednesday, Oct. 25, 2023. A webcast to discuss the results will be held Thursday, Oct. 26, 2023, at 9:30 a.m. Eastern Time (8:30 a.m. Central Time). To access the webcast, listeners should visit the Baker Hughes website at: investors.bakerhughes.com. An archived version will be available on the website following the webcast. About Baker Hughes:Baker Hughes (NASDAQ: BKR) is an energy technology company that provides solutions to energy and industrial customers worldwide. Built on a century of experience and conducting business in over 120 countries, our innovative technologies and services are taking energy forward...

Continue reading

GBT Receives Patent Grant Notification Covering its Integrated Circuits Reliability Verification Analysis and Auto-Correction Technology

The Patent is scheduled for Grant on September 19, 2023 SAN DIEGO, Sept. 07, 2023 (GLOBE NEWSWIRE) — GBT Technologies Inc. (OTC PINK: GTCH) (“GBT” or the “Company”), received a grant notification for its microchip’s reliability verification and auto-correction EDA patent application, internal project’s code name, Epsilon. The patent will be granted as U.S. Patent No. 11,763,062 on September 19, 2023. GBT’s Epsilon patent application covers the innovative technology to address advanced semiconductor node physics with the goal of ensuring a high level of reliability, optimal thermal design, lower power consumption and high performance. The described technology includes machine learning algorithms to enable robust design, process optimization, characterization, modeling, and simulation. The technology underlying the patent identifies...

Continue reading

First American Uranium Reports on New Mexico’s Past Uranium Mining and Potential at Red Basin Project

New Mexico ranks second in US-based uranium reserves The Grants district produced more uranium for 30+ years than any other US district First American Uranium’s Red Basin Uranium/Vanadium Property is located in the Grants districtVancouver, British Columbia, Sept. 07, 2023 (GLOBE NEWSWIRE) — First American Uranium Inc. (CSE: URM) (FSE: IOR) (OTCPK: FAUMF) (the “Company”) is pleased to provide information on past exploration and production of uranium in New Mexico, specifically in the region of the Company’s Red Basin Uranium/Vanadium Property located in the Grants district, which contains the state’s most important uranium deposits. Over 340 million pounds of U3O8 were produced from these deposits in northwestern New Mexico from 1948 to 2002, accounting for 97% of the state’s total production and exceeding...

Continue reading

Global Crossing Airlines Announces Agreement to Finance Construction of its new Maintenance Facility

MIAMI, Sept. 07, 2023 (GLOBE NEWSWIRE) — Global Crossing Airlines Group, Inc. (JET: NEO; JET.B: NEO; JETMF: OTCQB) (the “Company” or “GlobalX”) is pleased to announce that is has reached an agreement with Sheltair Aviation for the financing and construction of a new aircraft maintenance facility at the Fort Lauderdale- Hollywood International Airport (KFLL). GlobalX expects to break ground on this new facility in Q4 2023, occupy the facility in Q2 2025, and to cost approx. $25 million to construct. “We are pleased that we are partnering with Sheltair to build our maintenance home base facility. This state-of-the-art facility will cover approximately 69,650 square feet of hangar, office and shop space, providing the capability to hold three A320 family aircraft or one A330 sized aircraft. This facility is vital to our growth and...

Continue reading

Recce Pharmaceuticals Announces RECCE® Trademark Registered in Vietnam, Strengthening Global IP Portfolio

SYDNEY, Australia, Sept. 07, 2023 (GLOBE NEWSWIRE) — Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q) (the Company), the Company developing a new class of synthetic anti-infectives, is pleased to announce it has been issued a trademark registration for RECCE® from the Intellectual Property Office of Vietnam, strengthening the Company’s global intellectual property (IP) portfolio. The International Trademark Registration No. 1289603 has been formally assigned to the International Bureau (World Intellectual Property Organization), classified under Class 5 for antibiotics, antibiotics for human use, and pharmaceutical preparations, namely mixed antibiotic preparations. “We are thrilled to receive this newly awarded trademark in Vietnam, further strengthening Recce’s intellectual property portfolio in the Asia-Pacific region,” said James...

Continue reading

Eyenovia to Present at Upcoming H.C. Wainwright 25th Annual Global Investment Conference

NEW YORK, Sept. 07, 2023 (GLOBE NEWSWIRE) — Eyenovia, Inc. (Nasdaq: EYEN), a commercial-stage ophthalmic technology company commercializing Mydcombi™ (tropicamide+phenylephrine ophthalmic spray for mydriasis) and developing the Optejet® device for use both in connection with its own drug-device therapeutic product candidates for presbyopia and pediatric progressive myopia as well as out-licensing for additional indications, today announced management will deliver a presentation at the H.C. Wainwright 25th Annual Global Investment Conference, which is taking place on September 11-13, 2023 at the Lotte New York Palace Hotel. H.C. Wainwright 25th Annual Global Investment ConferenceFormat: On-DemandAvailable: Beginning Monday, September 11, 2023 at 7:00am ETWebcast: https://journey.ct.events/view/002ac4ec-0d8d-4aa9-8c0f-c72b5bec025dThe...

Continue reading

electroCore to Participate in the H.C. Wainwright 25th Annual Global Investment Conference

ROCKAWAY, N.J., Sept. 07, 2023 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that Company CEO, Dan Goldberger, will present at the H.C. Wainwright 25th Annual Global Investment Conference. H.C. Wainwright 25th Annual Global Investment Conference:Date: Monday, September 11, 2023Time: Recorded presentation available starting at 7:00 am ETEvent: Company Presentation For more information regarding the conference and to register, please visit the conference page here. About electroCore, Inc.electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company dedicated to improving health through its non-invasive vagus nerve stimulation (“nVNS”) technology platform. Our focus is the commercialization of medical devices for the management...

Continue reading

Worksport Announces Strong Solar Panel Supply Partner for SOLIS, Focusing On Bringing SOLIS Solar Cover and COR Battery System To Market

West Seneca, N.Y., Sept. 07, 2023 (GLOBE NEWSWIRE) — Worksport (Nasdaq: WKSP; WKSPW) is elated to announce that it has found a top-tier solar panel provider for its highly anticipated SOLIS Solar Tonneau Cover. This partner is renowned for their state-of-the-art solar panels and underlying technology. A supply partner will help set a new standard in renewable energy tech for vehicles and to provide the most durable and highest quality flexible solar panels. With this supply partner for SOLIS, the Company is demonstrating its unwavering commitment to pioneering sustainable technological solutions. The sample solar panels presented to Worksport and tested in Worksport’s SOLIS Solar Cover epitomize resilience and innovation. Adhering to rigorous environmental and structural standards, these panels incorporate high-quality components...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.